Found: 18
Select item for more details and to access through your institution.
Immunogenicity and Reactogenicity of a Reduced Schedule of a 4-component Capsular Group B Meningococcal Vaccine: A Randomized Controlled Trial in Infants.
- Published in:
- Open Forum Infectious Diseases, 2020, v. 7, n. 5, p. 1, doi. 10.1093/ofid/ofaa143
- By:
- Publication type:
- Article
Serogroup C Neisseria meningitidis disease epidemiology, seroprevalence, vaccine effectiveness and waning immunity, England, 1998/99 to 2015/16.
- Published in:
- Eurosurveillance (15607917), 2019, v. 24, n. 1, p. 17, doi. 10.2807/1560-7917.ES.2019.24.1.1700818
- By:
- Publication type:
- Article
Seroprevalence of Bactericidal, Specific IgG Antibodies and Incidence of Meningitis Due to Group A <i>Neisseria meningitidis</i> by Age in Burkina Faso 2008.
- Published in:
- PLoS ONE, 2013, v. 8, n. 2, p. 1, doi. 10.1371/journal.pone.0055486
- By:
- Publication type:
- Article
Correlation of Group C Meningococcal Conjugate Vaccine Response with B- and T-Lymphocyte Activity.
- Published in:
- PLoS ONE, 2012, v. 7, n. 2, p. 1, doi. 10.1371/journal.pone.0031160
- By:
- Publication type:
- Article
Three Cases of Invasive Meningococcal Disease Caused by a Capsule Null Locus Strain Circulating among Healthy Carriers in Burkina Faso.
- Published in:
- Journal of Infectious Diseases, 2007, v. 195, n. 7, p. 1071, doi. 10.1086/512084
- By:
- Publication type:
- Article
Antibody Persistence at the Population Level 5 Years After Mass Vaccination With Meningococcal Serogroup A Conjugate Vaccine (PsA-TT) in Burkina Faso: Need for a Booster Campaign?
- Published in:
- Clinical Infectious Diseases, 2019, v. 68, n. 3, p. 435, doi. 10.1093/cid/ciy488
- By:
- Publication type:
- Article
Antibody Responses After Primary Immunization in Infants Born to Women Receiving a Pertussis-containing Vaccine During Pregnancy: Single Arm Observational Study With a Historical Comparator.
- Published in:
- Clinical Infectious Diseases, 2015, v. 61, n. 11, p. 1637, doi. 10.1093/cid/civ695
- By:
- Publication type:
- Article
Neisseria meningitidis Group A IgG1 and IgG2 Subclass Immune Response in African Children Aged 12–23 Months Following Meningococcal Vaccination.
- Published in:
- Clinical Infectious Diseases, 2015, v. 61, p. S563, doi. 10.1093/cid/civ505
- By:
- Publication type:
- Article
Human Complement Bactericidal Responses to a Group A Meningococcal Conjugate Vaccine in Africans and Comparison to Responses Measured by 2 Other Group A Immunoassays.
- Published in:
- Clinical Infectious Diseases, 2015, v. 61, p. S554, doi. 10.1093/cid/civ504
- By:
- Publication type:
- Article
Population-Level Persistence of Immunity 2 Years After the PsA-TT Mass-Vaccination Campaign in Mali.
- Published in:
- Clinical Infectious Diseases, 2015, v. 61, p. S547, doi. 10.1093/cid/civ602
- By:
- Publication type:
- Article
Meningococcal Seroepidemiology 1 Year After the PsA-TT Mass Immunization Campaign in Burkina Faso.
- Published in:
- Clinical Infectious Diseases, 2015, v. 61, p. S540, doi. 10.1093/cid/civ519
- By:
- Publication type:
- Article
Antibody Persistence at 1 and 4 Years Following a Single Dose of MenAfriVac or Quadrivalent Polysaccharide Vaccine in Healthy Subjects Aged 2–29 Years.
- Published in:
- Clinical Infectious Diseases, 2015, v. 61, p. S521, doi. 10.1093/cid/civ518
- By:
- Publication type:
- Article
Antibody Persistence 1–5 Years Following Vaccination With MenAfriVac in African Children Vaccinated at 12–23 Months of Age.
- Published in:
- Clinical Infectious Diseases, 2015, v. 61, p. S514, doi. 10.1093/cid/civ672
- By:
- Publication type:
- Article
Correction: A Seroepidemiological Study of Serogroup A Meningococcal Infection in the African Meningitis Belt.
- Published in:
- 2016
- By:
- Publication type:
- Correction Notice
A Seroepidemiological Study of Serogroup A Meningococcal Infection in the African Meningitis Belt.
- Published in:
- PLoS ONE, 2016, v. 11, n. 2, p. 1, doi. 10.1371/journal.pone.0147928
- By:
- Publication type:
- Article
Immunogenicity and Safety of a Meningococcal Serogroup A, C, Y and W Glycoconjugate Vaccine, ACWY-TT.
- Published in:
- Advances in Therapy, 2013, v. 30, n. 5, p. 431, doi. 10.1007/s12325-013-0032-5
- By:
- Publication type:
- Article
Investigation of correlates of protection against pharyngeal carriage of Neisseria meningitidis genogroups W and Y in the African meningitis belt.
- Published in:
- PLoS ONE, 2017, v. 12, n. 8, p. 1, doi. 10.1371/journal.pone.0182575
- By:
- Publication type:
- Article
Kinetics of Immune Responses to Nasal Challenge With Meningococcal Polysaccharide One Year After Serogroup-C Glycoconjugate Vaccination.
- Published in:
- Clinical Infectious Diseases, 2011, v. 52, n. 11, p. 1317, doi. 10.1093/cid/cir198
- By:
- Publication type:
- Article